Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro (2013)
- Authors:
- USP affiliated authors: OLIVEIRA, HARLEY FRANCISCO DE - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidade: FMRP
- DOI: 10.1089/cbr.2012.1305
- Subjects: OSTEOSSARCOMA; RADIOTERAPIA
- Language: Inglês
- Imprenta:
- Publisher place: New Rochelle
- Date published: 2013
- Source:
- Título: Cancer Biotherapy and Radiopharmaceuticals
- ISSN: 1084-9785
- Volume/Número/Paginação/Ano: v. 28, n. 4, p. 351-358, 2013
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BRASSESCO, María Sol et al. Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro. Cancer Biotherapy and Radiopharmaceuticals, v. 28, n. 4, p. 351-358, 2013Tradução . . Disponível em: https://doi.org/10.1089/cbr.2012.1305. Acesso em: 27 dez. 2025. -
APA
Brassesco, M. S., Pezuk, J. A., Oliveira, J. C. de, Valera, E. T., Oliveira, H. F. de, Scrideli, C. A., et al. (2013). Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro. Cancer Biotherapy and Radiopharmaceuticals, 28( 4), 351-358. doi:10.1089/cbr.2012.1305 -
NLM
Brassesco MS, Pezuk JA, Oliveira JC de, Valera ET, Oliveira HF de, Scrideli CA, Umezawa K, Tone LG. Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro [Internet]. Cancer Biotherapy and Radiopharmaceuticals. 2013 ; 28( 4): 351-358.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1089/cbr.2012.1305 -
Vancouver
Brassesco MS, Pezuk JA, Oliveira JC de, Valera ET, Oliveira HF de, Scrideli CA, Umezawa K, Tone LG. Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro [Internet]. Cancer Biotherapy and Radiopharmaceuticals. 2013 ; 28( 4): 351-358.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1089/cbr.2012.1305 - Characterization of LGALS3 (galectin-3) as a player in DNA damage response
- Cytostatic in vitro effects of DTCM-Glutarimide on bladder carcinoma cells
- In vitro targeting of polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors
- Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation
- Tetraploidization in Wilms tumor in an infant
- Bloom's and myelodysplastic syndromes: report of a rare pediatric case with gain of an isochromosome 5p. [Carta]
- Alternative targets for medulloblastoma treatment: polo-like kinase 1
- Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines
- Inibição de exportina 7 (XPO7) sensibiliza linhagens de leucemia linfóide aguda para o tratamento com glicocorticoide
- Effects of zebularine alone or in combination with the histone deacetylase inhibitor SAHA on medulloblastoma cells
Informações sobre o DOI: 10.1089/cbr.2012.1305 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
